CClinicalTrials.gg
WithdrawnNCT03955718Updated Jul 22, 2020

Developing and Testing Motherly App: a Smartphone Application to Promote Mothers' Mental Health

An interventional study of Motherly App and Educational App (Active Control) in Maternal Depression, sponsored by University of Sao Paulo. Withdrawn at 1 site in Brazil. Open to female participants aged 16 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-07-22.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Prevention

Why this study was withdrawn
The study stopped because of delays in the development of the smartphone app intervention
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
16 Years to 40 Years
Sex
Female
01

Study summary

The investigators plan to develop and test Motherly, a smartphone app to promote maternal mental health and child development. The Motherly app is visually appealing aimed at engaging the user with a minimalistic layout. The app will offer a gamified experience ideal for engaging youth in behaviors that can promote mental health, such as stimulating pleasure, productivity, and physical activities, connecting with peers, and eating healthy food. Pregnant women aged 16-34 living in Brazil will participate in the clinical trial to test the efficacy of the intervention.

02

Conditions studied

  • Maternal Depression

Browse trials for

03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

Browse Depression studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Literate women in the first or second trimester of pregnancy
  • Living in Brazil
  • Owning a functional smartphone for personal use with Android or iOS operational system

Exclusion criteria

Exclusion Criteria:

  • High-risk pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Motherly App

    A smartphone app with an automated intervention that provides strategies to prevent maternal depression and to promote child development: (1) behavioral activation, (2) sleep hygiene, (3) physical activity, (4) social support, (5) nutrition, (6) prenatal care schedule, and (7) educational content.

    Behavioral: Motherly App

  • Active comparator
    Educational App (Active Control)

    An app with educational content about gestation, maternal health and mental health, child development, etc.

    Behavioral: Educational App (Active Control)

Interventions

  • BehavioralMotherly App

    The Motherly app is a behavioral intervention aimed at preventing maternal depression and promoting child development.

  • BehavioralEducational App (Active Control)

    An app with educational content about gestation, maternal health and mental health, child development, etc.

06

What researchers measure

Primary outcomes

  1. Maternal depression

    Maternal depression measured by the Patient Health Questionnaire (PHQ-9), less than 10 points in the scale

    Time frame: At 3 months of the child's age

Secondary outcomes

  1. Quality of sleep: Bergen Insomnia Scale

    Quality of sleep measured by the Bergen Insomnia Scale

    Time frame: Monthly up to 3 months of the child's age

  2. Quality of maternal diet: questionnaire

    Quality of maternal diet measured by a 14-item questionnaire developed for the present study.

    Time frame: Monthly up to 3 months of the child's age

  3. Physical activity

    Physical activity measured by accelerator data from the smartphone.

    Time frame: Monthly up to 3 months of the child's age

  4. Psychological well-being

    Psychological well-being measured by the Ryff's Psychological well-being scales

    Time frame: Monthly up to 3 months of the child's age

  5. General well-being

    WHO-5 Well-Being Index

    Time frame: 3 months of the child's age

  6. Maternal anxiety

    Maternal anxiety measured by the General Anxiety Disorder 7 scale

    Time frame: 3 months of the child's age

  7. Maternal self-efficacy: General Self-efficacy Scale

    Maternal self-efficacy measured by the General Self-efficacy Scale

    Time frame: 3 months of the child's age

  8. Quality of stimulation and support available to the child in the home environment: Home Observation for Measurement of the Environment

    Quality of stimulation and support available to the child in the home environment measured by the Home Observation for Measurement of the Environment

    Time frame: 3 months of the child's age

  9. Maternal parenting stress

    Maternal parenting stress measured by the Parenting Stress Index (PSI)

    Time frame: 3 months of the child's age

  10. Child development

    Child developmental milestones measured by in-app questions

    Time frame: After child birth up to 3 months of the child's age

  11. Child developmental milestones

    Child developmental milestones measured by the Survey of Well-being of Young Children (SWYC)

    Time frame: 3 months of the child's age

07

Study locations

1 site
  • Daniel Fatori
    São Paulo, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03955718
Lead sponsor
University of Sao Paulo
Collaborators
Grand Challenges Canada, Fundação Maria Cecilia Souto Vidigal
Responsible party
Guilherme Vanoni Polanczyk, MD PhD (Professor, University of Sao Paulo) — Principal investigator
First posted
May 20, 2019
Start date
Sep 25, 2019 (estimated)
Primary completion
May 1, 2020 (estimated)
Completion
Jun 1, 2020 (estimated)
Last update
Jul 22, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion